0001638599-16-000695.txt : 20160229 0001638599-16-000695.hdr.sgml : 20160229 20160229172434 ACCESSION NUMBER: 0001638599-16-000695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141217 FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Regan William J. CENTRAL INDEX KEY: 0001559381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 161469722 MAIL ADDRESS: STREET 1: NAVIDEA BIOPHARMACEUTICALS, INC. STREET 2: 425 METRO PLACE NORTH - SUITE 450 CITY: DUBLIN STATE: OH ZIP: 43017 4 1 doc4_678.xml PRIMARY DOCUMENT X0306 4 2014-12-17 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001559381 Regan William J. 5600 BLAZER PARKWAY, SUITE 200 DUBLIN OH 43017-7550 0 1 0 0 SVP-Global Regulatory Strategy Stock Option (Right to Buy) 1.5 2014-12-17 4 A 0 25000 0 A 2024-12-17 Common Stock 25000 25000 D Option vests as to 6,250 shares upon grant, with balance vesting at the rate of 6,250 shares on January 28 in each of 2016, 2017 and 2018. William J. Kelly, Attorney-in-Fact 2014-12-18